SafariSpinSafari| *ST Target Pharmaceutical: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects

News summary

[ST Eye DrugsSafariSpinSafari: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects] Securities Times e Company News, *ST Eye Pharmaceutical (600671) announced on the evening of May 23 that the wholly-owned subsidiary Huangshan Tianmu plans to invest about 100 million yuan. Build a new production workshop in the existing factory area and optimize and transform the original productionSafariSpinSafari.SafariSpinSafari..

Newsletter text

[ST Eye DrugsSafariSpinSafari: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects] Securities Times e Company News, *ST Eye Pharmaceutical (600671) announced on the evening of May 23 that the wholly-owned subsidiary Huangshan Tianmu plans to invest about 100 million yuan. Build a new production workshop in the existing factory area, optimize and transform the original production line, increase production capacity, build an intelligent, digital and information-based factory, and become a modern traditional Chinese medicine production enterprise with market competitiveness.